Chemo Pharma Lab

Chemo_Pharma_Lab29 Apr 2024

Pharmaceuticals

₹

-4.26 (-5.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Chemo Pharma Lab

Chemo Pharma Lab

Pharmaceuticals

Chemo_Pharma_Lab29 Apr 2024

₹

-4.26 (-5.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
09-Jan-2024	BC	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve 1. the Un-Audited Financial Stat	29-Jan-2024
16-Oct-2023	BC	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve the Un-Audited Financial Statem	27-Oct-2023
27-Jul-2023	BC	Approval of Un-Audited Financial Results of the Company for the Quarter Ended June 30, 2023 along with the Limited Review Report thereon. Intimation of Book Closure Pursuant to the Regulation 42(2	25-Sep-2023
27-Jul-2023	BC	Annual General Meeting	19-Sep-2023
14-Jul-2023	BC	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 inter alia to consider and approve 1. the Un-Audited Financial Resu	27-Jul-2023

No Rights has been declared by Chemo_Pharma_Lab

Book Closure

Record Date	Split Date	Purpose
29-Jan-2024	-	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve 1. the Un-Audited Financial Stat
27-Oct-2023	-	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve the Un-Audited Financial Statem
25-Sep-2023	-	Approval of Un-Audited Financial Results of the Company for the Quarter Ended June 30, 2023 along with the Limited Review Report thereon. Intimation of Book Closure Pursuant to the Regulation 42(2
19-Sep-2023	01 Jan'1900	Annual General Meeting
27-Jul-2023	-	CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 inter alia to consider and approve 1. the Un-Audited Financial Resu

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Chemo Pharma Laboratories Ltd ₹80.94(-4.26/-5.00%)	80.94	-4.26	12.78	122.16	9.51	1.03
Astrazeneca Pharma India Ltd ₹5,529.25(+113.85/2.10%)	5,529.25	+113.85	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹125.15(+2.55/2.08%)	125.15	+2.55	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,410.25(+0.85/0.06%)	1,410.25	+0.85	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹26,188.75(+323.90/1.25%)	26,188.75	+323.90	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹700.45(+19.60/2.88%)	700.45	+19.60	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.70	0.46	0.43	-0.10	0.19	0.59
Total Income	0.70	0.46	0.43	-0.10	0.19	0.59
Total Expenditure	0.02	0.02	0.05	0.02	0.02	0.05
PBIDT	0.68	0.44	0.38	-0.12	0.17	0.54
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	0.68	0.44	0.38	-0.12	0.17	0.54
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.13	0.00	0.00
Deferred Tax	0.00	0.00	0.00	-0.10	0.00	0.00
Reported Profit After Tax	0.68	0.44	0.38	-0.15	0.16	0.53
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.68	0.44	0.38	-0.15	0.16	0.53

EPS (Unit Curr.)	4.51	2.93	2.51	-0.99	1.08	3.56
EPS (Adj) (Unit Curr.)	4.51	2.93	2.51	-0.99	1.08	3.56
Calculated EPS (Unit Curr.)	4.51	2.93	2.51	-0.99	1.08	3.56
Calculated EPS (Adj) (Unit Curr.)	4.51	2.93	2.51	-0.99	1.08	3.56
Calculated EPS (Ann.) (Unit Curr.)	18.03	11.72	10.03	-3.95	4.32	14.24
Calculated EPS (Adj) (Ann.) (Unit Curr.)	18.03	11.72	10.03	-3.95	4.32	14.24
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	1.50	1.50	1.50	1.50	1.50	1.50
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	1.50	1.50	1.50	1.50	1.50	1.50
Reserves Total	10.10	10.05	9.49	9.24	8.83	8.62
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	11.60	11.55	10.99	10.74	10.33	10.12
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	11.60	11.55	10.99	10.74	10.33	10.12
APPLICATION OF FUNDS :
Gross Block	0.11	0.11	0.11	0.11	0.01	0.01
Less : Accumulated Depreciation	0.09	0.07	0.06	0.03	0.01	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.02	0.04	0.05	0.08	0.00	0.01
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3.03	2.94	0.04	0.02	0.04	0.02
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	0.00	0.00	0.00	0.00	0.00	0.00
Cash and Bank	6.06	6.19	10.87	8.81	2.97	7.66
Loans and Advances	0.07	0.11	0.09	0.10	5.57	0.88
Total Current Assets	6.13	6.30	10.96	8.91	8.54	8.55
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.01	0.01	0.01	0.14	0.13	0.12
Provisions	0.01	0.10	0.05	0.08	-0.03	0.01
Total Current Liabilities	0.02	0.11	0.06	0.22	0.09	0.13
Net Current Assets	6.11	6.19	10.90	8.69	8.45	8.41
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.24	0.26	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.24	0.26	0.00	0.00	0.00	0.00
Total Assets	9.41	9.43	10.99	8.78	8.49	8.43
Contingent Liabilities	0.00	0.01	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.69	2.17	0.81	2.97	7.66
Net Cash from Operating Activities	-0.68	-0.33	-0.41	4.83	-5.48
Net Cash Used In Investing Activities	0.63	0.97	-0.19	1.01	0.79
Net Cash Used In Financing Activities	-0.08	-2.12	1.96	0.00	0.00
Net Inc./Dec In Cash And Cash Equivalents	-0.13	-1.49	1.36	5.84	-4.70
Cash And Cash Equivalents At End Of The Year	0.56	0.69	2.17	8.81	2.97

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

27.89%

FII Shareholding

0.00%

DII Shareholding

0.37%

Public Shareholding

71.75%

**Promoter pledged shareholding 27.89%

About Chemo Pharma Laboratories Ltd

Chemo Pharma Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 12.78 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0.68 crores for the quarter ended December 2018. The company management includes , Ashok Somani,Toby Antony,Shanta Somani,Mathura Prasad Sharma,Bhavin Sheth,Nandkumar Pareek,Unnatti Jain (Chemo Pharma Laboratories Ltd) among others.

Chairman

Registered office

5 Kumud Apartment CHS Ltd,Karnik Road Chikan Ghar Kalyan,Thane,Maharashtra,421301

FAX :

Background

Incorporation Year1942

Face Value₹10

Market Lot1

How to buy Chemo Pharma Lab shares on nse?

To buy Chemo Pharma Lab shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Chemo Pharma Lab share price today?

The Chemo Pharma Lab shares price on nse is Rs.80.94 today.

What is the market cap of Chemo Pharma Lab shares on BSE ?

The company has a market capitalization of Rs.12.78Cr

What is the PE & PB ratio of Chemo Pharma Lab shares ?

PE is 9.51 and PB is 1.03

What is the 52 Week High and Low of Chemo Pharma Lab shares?

Chemo Pharma Lab stock price high: Rs.87 Chemo Pharma Lab stock price low: Rs.27.17